MX9204613A - Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares - Google Patents

Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares

Info

Publication number
MX9204613A
MX9204613A MX9204613A MX9204613A MX9204613A MX 9204613 A MX9204613 A MX 9204613A MX 9204613 A MX9204613 A MX 9204613A MX 9204613 A MX9204613 A MX 9204613A MX 9204613 A MX9204613 A MX 9204613A
Authority
MX
Mexico
Prior art keywords
treatment
procedures
preparation
cardiovascular diseases
organic nitrates
Prior art date
Application number
MX9204613A
Other languages
English (en)
Inventor
Jean-Pierre Nallet
Jacques Dreux
Alain Berdeaux
Vicent Richard
Piero Martorana
Helmut Bohn
Original Assignee
Lab Hoechst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Hoechst filed Critical Lab Hoechst
Publication of MX9204613A publication Critical patent/MX9204613A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen nitratos orgánicos, procedimientos para su preparación y su uso en el tratamiento de enfermedades cardiovasculares y en particular en el tratamiento de angina. Tales nitratos corresponden a la fórmula (I)
MX9204613A 1991-08-07 1992-08-07 Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares MX9204613A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9110039A FR2680173A1 (fr) 1991-08-07 1991-08-07 Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .

Publications (1)

Publication Number Publication Date
MX9204613A true MX9204613A (es) 1993-09-01

Family

ID=9415992

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204613A MX9204613A (es) 1991-08-07 1992-08-07 Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares

Country Status (10)

Country Link
US (1) US5591758A (es)
EP (2) EP0604459A1 (es)
JP (1) JPH07500817A (es)
CA (1) CA2113922A1 (es)
FR (1) FR2680173A1 (es)
HU (1) HUT70546A (es)
MX (1) MX9204613A (es)
TW (1) TW213906B (es)
WO (1) WO1993003037A1 (es)
ZA (1) ZA925892B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US6284790B1 (en) * 2000-06-15 2001-09-04 Sachin Gupte Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
US20040019206A1 (en) * 2001-09-27 2004-01-29 Peter Ruminiski Lactone integrin antagonists
US20040254238A1 (en) * 2003-04-07 2004-12-16 Osteoscreen Bone growth stimulation with NO/statin and other NO modulating combinations
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP2149576A1 (en) 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
US7807716B2 (en) * 2008-09-24 2010-10-05 Oral Delivery Technology Ltd. Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
EP2722326A1 (en) 2011-10-24 2014-04-23 Nicox S.A. Quinone based nitric oxide donating compounds
US9540391B2 (en) 2013-01-17 2017-01-10 Sanofi Isomannide derivatives as inhibitors of soluble epoxide hydrolase
WO2014169976A1 (en) 2013-04-18 2014-10-23 Nicox Science Ireland Quinone based nitric oxide donating compounds
CN103897023A (zh) * 2014-02-28 2014-07-02 苏州维泰生物技术有限公司 一种合成甘氨酸半胱氨酸伪二肽模块的新方法
US10913748B2 (en) * 2018-11-04 2021-02-09 Coeurative, Inc. Compounds useful for treating cardiovascular diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1204571B (it) * 1987-05-08 1989-03-10 Chiesi Farma Spa Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
JP2628756B2 (ja) * 1988-09-15 1997-07-09 シュバルツファルマ アクチェンゲゼルシャフト 新規有機ニトレート及びそれらの製造方法
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.

Also Published As

Publication number Publication date
ZA925892B (en) 1993-07-28
EP0530887A1 (fr) 1993-03-10
HU9400327D0 (en) 1994-05-30
CA2113922A1 (fr) 1993-02-18
TW213906B (es) 1993-10-01
WO1993003037A1 (fr) 1993-02-18
EP0604459A1 (fr) 1994-07-06
JPH07500817A (ja) 1995-01-26
HUT70546A (en) 1995-10-30
FR2680173B1 (es) 1995-05-05
US5591758A (en) 1997-01-07
FR2680173A1 (fr) 1993-02-12

Similar Documents

Publication Publication Date Title
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
DK0579615T3 (da) Nye estere af bi- og tricykliske aminoalkoholer, fremstilling deraf og anvendelse deraf i lægemidler
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2049690T3 (es) Derivados de taxano, su preparacion y su uso en oncologia.
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
ES2179864T3 (es) 4-benzoil-isoxazoles y su uso como herbicidas.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
FI872236A0 (fi) Foerfarande foer framstaellning av synergistinderivat.
ES2188909T3 (es) Nuevos derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes o enfermedades relacionados con el estrogeno. os
ES2085051T3 (es) Usos de 1,1,1,3,3,3-hexafluoropropano.